"Le service du Professeur Cellier prend en charge l’ensemble des maladies du tube digestif, du foie, des voies biliaires et du pancréas."

During the past decade, Hop Europeen Georges Pompidou; Gastro Enterologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hop Europeen Georges Pompidou; Gastro Enterologie" are "Colorectal Cancer" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Hop Europeen Georges Pompidou; Gastro Enterologie" in a lesser frequency.

Most popular intervention types in "Hop Europeen Georges Pompidou; Gastro Enterologie" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Taxane" (1 trials) and "trastuzumab emtansine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hop Europeen Georges Pompidou; Gastro Enterologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hop Europeen Georges Pompidou; Gastro Enterologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hop Europeen Georges Pompidou; Gastro Enterologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hop Europeen Georges Pompidou; Gastro Enterologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".